Poop pills? fecal transplant trial aims to calm IBS stomachs
NCT ID NCT05776914
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a fecal transplant from a carefully selected donor can reduce symptoms in people with moderate to severe IBS. The donor stool has low levels of certain proteins that may trigger IBS. 43 participants will receive the transplant during a colonoscopy and be followed for 12 weeks to see if their symptoms improve.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Minnesota
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could simple exercises calm gut inflammation and boost quality of life in IBS?
- Can a postbiotic soothe diarrhea in vulnerable kids?
- Gut bacteria during infection may flag IBS risk
- Wheat sensitivity linked to fatty liver? a new study investigates
- School health rooms and trained teachers: a new hope for Zambia's children?
- Could a daily probiotic capsule tame irritable bowel syndrome?